Main Content
News - Alberta
Alberta government expands insulin coverage
EDMONTON, ALBERTA (February 3, 2012) The Canadian Diabetes Association applauds the Government of Alberta for increasing access to long acting insulin known as Lantus (insulin glargine) and Levemir (insulin detemir) for Albertans living with diabetes. This week both drugs were added to the provincial drug formulary, providing more options for diabetes patients when other insulin treatments do not effectively control blood glucose levels. Lantus and Levemir may provide up to 24 hours of blood glucose control and can help reduce the risk of hypoglycemia in some patients.
“This is a positive step in ensuring those with diabetes in Alberta have access to medication that helps them manage their condition,” said Laura Kemp, Regional Director for the Canadian Diabetes Association, Alberta and NWT. “We applaud the Government of Alberta for providing coverage for alternative insulin therapy options.”
Insulin is a hormone produced by the pancreas to control the amount of glucose (sugar) in the blood. In people who have diabetes, the pancreas does not produce any or enough insulin, or is unable to effectively use the insulin it does produce. As a result, glucose builds up in the bloodstream, potentially leading to serious health problems such as blindness, heart disease, kidney problems, amputation, nerve damage and erectile dysfunction.
-30-
About the Canadian Diabetes Association
Today, more than nine million Canadians live with diabetes or prediabetes. Across the country, the Canadian Diabetes Association is leading the fight against diabetes by helping people with diabetes live healthy lives while we work to find a cure. Our community-based network of supporters help us provide education and services to people living with diabetes, advocate for our cause, break ground towards a cure and translate research into practical applications. For more information, please visit diabetes.ca or call 1-800-BANTING (226-8464).
For additional information or to schedule an interview, please contact:
Katie Ostler
Canadian Diabetes Association, AB & NWT
Office: 780-423-5722 x 240
Cell: 780-504-498
 |
Support the Canadian Diabetes Association! |